Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis (scientific article published on 11 January 2011)

Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy

Q28143683

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

Q28239579

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index

Q28299001

Bone density, ultrasound measurements and body composition in early ankylosing spondylitis

Q30700518

Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis

Q33566110

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria

Q34055060

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index

Q34307327

How should clinicians manage osteoporosis in ankylosing spondylitis?

Q34756986

Osteoporosis and vertebral fractures in ankylosing spondylitis

Q36841353

Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis.

Q42166632

Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis

Q43927224

Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis

Q68044844

Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures

Q73101160

Osteoporosis, body composition, and bone turnover in ankylosing spondylitis

Q73101162

Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study

Q73165844

Bone mineral density in mild and advanced ankylosing spondylitis

Q73589842

Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study

Q74437053

Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis

Q74582750

Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis

Q77766900

Bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients: relationship to disease activity

Q79235364

Bone and matrix remodeling markers: a new tool for assessment of treatment efficacy in ankylosing spondylitis?

Q80791246

Osteopenia in men with mild and severe ankylosing spondylitis

Q80852717

P433

issue

P921

main subject

ankylosing spondylitis

Q52849

P304

page(s)

691-695

P577

publication date

2011-01-11

P1433

published in

Clinical Rheumatology

Q15754927

P1476

title

Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis

P478

volume

Reverse relations

cites work (P2860)

Q89099266	Alteration of Bone Turnover Markers in Canonical Wingless Pathway in Patients With Ankylosing Spondylitis
Q82519059	Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study
Q44361753	Comparison of PA spine, lateral spine, and femoral BMD measurements to determine bone loss in ankylosing spondylitis
Q27025982	Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management
Q38670399	Osteoporosis Management in Ankylosing Spondylitis.
Q35931065	Serum Vitamin D and Pyridinoline Cross-Linked Carboxyterminal Telopeptide of Type I Collagen in Patients with Ankylosing Spondylitis

P356	DOI	10.1007/S10067-010-1648-3
P698	PubMed publication ID	21221691